Reantis Pharmacuticals Private Limited
About Reantis Pharmacuticals Private Limited
Data last updated:
Reantis Pharmacuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 30 March 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ2001PTC039375. Its GSTIN is 24AABCR9823Q1ZS (Gujarat).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.05 Lakh. It is led by directors Sudhir Mohanlal Kothari and Jagdishbhai Rathod.
Its last annual general meeting (AGM) was held on 03 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 21 Cellar Neptune Tower Opp.Nehru Bridge Ashram Road, Ahmedabad, Gujarat, India – 380006.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.03 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹4,585 (net margin 0%) and EBITDA of ₹4.06 Lakh (EBITDA margin 3.9%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Reantis Pharmacuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address21 Cellar Neptune Tower Opp.Nehru Bridge Ashram Road, Ahmedabad, Gujarat, India – 380006
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Reantis Pharmacuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Reantis Pharmacuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Reantis Pharmacuticals Private Limited, buy the company report.
Financials of Reantis Pharmacuticals Private Limited
FY 2025 filings availableReantis Pharmacuticals Private Limited reported revenue of ₹1.03 Cr (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 3% fall in the latest year. EBITDA rose 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.06 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4,585 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Reantis Pharmacuticals Private Limited, buy the company report.
Board of directors of Reantis Pharmacuticals Private Limited
Reantis Pharmacuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudhir Mohanlal Kothari | Director | 30 Mar 2001 | 25 Years 7 Months | Current |
| Jagdishbhai Rathod | Director | 21 Aug 2019 | 7 Years 2 Months | Current |
Peer comparison
Reantis Pharmacuticals Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zelence Industries Private Limited | ₹1.03 Cr (FY 2025) | -27.0% | Kharagpur, West Bengal, India | |||
| Dilip Majumder Udyog Private Limited | ₹1.03 Cr (FY 2025) | 16.0% | Kolkata, West Bengal, India | |||
| Azurite Bio Science Private Limited | ₹1.03 Cr (FY 2024) | 70.0% | Jayanagar, Karnataka, India | |||
| Grow-Ved India Private Limited | ₹1.03 Cr (FY 2025) | -51.0% | Ambala City Ho, Haryana, India | |||
| Delightful Beauty Accessories Private Limited | ₹1.03 Cr (FY 2019) | Nagpur, Maharashtra, India | ||||
| Reantis Pharmacuticals Private Limitedthis company | ₹1.03 Cr (FY 2025) | ₹4,585 | 0% | -3.0% | Ahmedabad, Gujarat, India | |
| Dhara Commosales Private Limited | ₹1.03 Cr (FY 2025) | 14.0% | Kolkata, West Bengal, India | |||
| Skat India Trading Private Limited | ₹1.03 Cr (FY 2024) | Chennai, Tamil Nadu, India | ||||
| TPNC Technology Private Limited | ₹1.03 Cr (FY 2025) | -31.0% | Indore, Madhya Pradesh, India | |||
| Gangasahai Naraindass Trading Private Limited | ₹1.03 Cr (FY 2025) | 359.0% | Lucknow, Uttar Pradesh, India | |||
| Preeti Ujjawal Transports and Constructions Private Limited | ₹1.03 Cr (FY 2025) | -65.0% | Nawada, Bihar, India |
To see the full peer comparison of Reantis Pharmacuticals Private Limited, buy the company report.
Auditor
Reantis Pharmacuticals Private Limited is audited by ACM&Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ACM&Associates | FY 2017 | 135206W |
Shareholding
The shareholding of Reantis Pharmacuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Reantis Pharmacuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Reantis Pharmacuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reantis Pharmacuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Reantis Pharmacuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AABCR9823Q1ZS | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Reantis Pharmacuticals Private Limited, buy the company report.
Recent activity
Reantis Pharmacuticals Private Limited has 5 board changes on record since 2001: 2 appointments and 3 cessations. The latest: Jagdishbhai Rathod ceased to be Additional Director on 17 Dec 2020.
Frequently asked questions
Reantis Pharmacuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in other wholesale, within the trading industry. It was incorporated on 30 March 2001 (25+ years old) and is registered under CIN U24231GJ2001PTC039375.
Reantis Pharmacuticals has 2 current directors:
- Sudhir Mohanlal Kothari - Director
- Jagdishbhai Rathod - Director
The latest financial statements of Reantis Pharmacuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 03 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Reantis Pharmacuticals is 24AABCR9823Q1ZS, registered in Gujarat.
The CIN (Corporate Identification Number) of Reantis Pharmacuticals is U24231GJ2001PTC039375. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reantis Pharmacuticals was incorporated on 30 March 2001, making it 25+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Reantis Pharmacuticals by revenue are Zelence Industries Private Limited, Dilip Majumder Udyog Private Limited, Azurite Bio Science Private Limited, Grow-Ved India Private Limited, Delightful Beauty Accessories Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Jagdishbhai Rathod ceased to be Additional Director on 17 Dec 2020. Vijaybhai Ratilal Parmar ceased to be Director on 22 Aug 2019. Jagdishbhai Rathod was appointed as Director on 21 Aug 2019. Reantis Pharmacuticals has 5 board changes on record in total.
The registered office of Reantis Pharmacuticals is at 21 Cellar Neptune Tower Opp.Nehru Bridge Ashram Road, Ahmedabad, Gujarat, India – 380006.
Reantis Pharmacuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Reantis Pharmacuticals is compliant as of 12 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
